Quarter Financials
Mereo BioPharma Group plc (MREO)
$1
+0.01 (+1.01%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| Net Income | - | - | - | - | -62 | - | - | - |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -316 | -297 | -298 | -310 | -271 | -146 | -127 | -111 |
|---|
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | 2 | 3 | 2 | 2 | 11 | 12 | 13 | 0 |
|---|
|
Year
|
2022 Q2
|
2021 Q4
|
2021 Q2
|
2020 Q4
|
2020 Q2
|
2019 Q4
|
2019 Q2
|
2018 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|